Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Novel lung adenocarcinoma and nuclear factor-kappa B (NF-κB) inhibitors: synthesis and evaluation of lantadene congeners.

Suthar SK, Boon HL, Sharma M.

Eur J Med Chem. 2014 Mar 3;74:135-44. doi: 10.1016/j.ejmech.2013.12.052. Epub 2014 Jan 8.

PMID:
24457265
2.

Synthesis of lantadene analogs with marked in vitro inhibition of lung adenocarcinoma and TNF-α induced nuclear factor-kappa B (NF-κB) activation.

Monika, Sharma A, Suthar SK, Aggarwal V, Lee HB, Sharma M.

Bioorg Med Chem Lett. 2014 Aug 15;24(16):3814-8. doi: 10.1016/j.bmcl.2014.06.068. Epub 2014 Jun 28.

PMID:
25027934
4.

Synthesis, selective cancer cytotoxicity and mechanistic studies of novel analogs of lantadenes.

Tailor NK, Jaiswal V, Lan SS, Lee HB, Sharma M.

Anticancer Agents Med Chem. 2013 Jul 1;13(6):957-66.

PMID:
23293887
5.

Differential regulation of RANTES and IL-8 expression in lung adenocarcinoma cells.

Henriquet C, Gougat C, Combes A, Lazennec G, Mathieu M.

Lung Cancer. 2007 May;56(2):167-74. Epub 2007 Jan 17.

7.
8.
9.
10.
11.

Cinobufocini inhibits NF-κB and COX-2 activation induced by TNF-α in lung adenocarcinoma cells.

Wang JY, Chen L, Zheng Z, Wang Q, Guo J, Xu L.

Oncol Rep. 2012 May;27(5):1619-24. doi: 10.3892/or.2012.1647. Epub 2012 Jan 19.

PMID:
22267101
12.

Sensitization of TNF-induced cytotoxicity in lung cancer cells by concurrent suppression of the NF-kappaB and Akt pathways.

Wang X, Chen W, Lin Y.

Biochem Biophys Res Commun. 2007 Apr 13;355(3):807-12. Epub 2007 Feb 12.

PMID:
17316570
13.

KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.

Schön M, Wienrich BG, Kneitz S, Sennefelder H, Amschler K, Vöhringer V, Weber O, Stiewe T, Ziegelbauer K, Schön MP.

J Natl Cancer Inst. 2008 Jun 18;100(12):862-75. doi: 10.1093/jnci/djn174. Epub 2008 Jun 10.

PMID:
18544741
14.
15.
17.

Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in human lung cancer cells.

Huang YC, Hsiao YC, Chen YJ, Wei YY, Lai TH, Tang CH.

Biochem Pharmacol. 2007 Dec 15;74(12):1702-12. Epub 2007 Aug 25.

PMID:
17904532
18.

Activation of NF-κB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKβ expression.

Chen PM, Wu TC, Wang YC, Cheng YW, Sheu GT, Chen CY, Lee H.

Carcinogenesis. 2013 Nov;34(11):2655-63. doi: 10.1093/carcin/bgt220. Epub 2013 Jun 19.

PMID:
23784082
19.

Aurora-A kinase regulates NF-kappaB activity: lessons from combination studies.

Linardopoulos S.

J BUON. 2007 Sep;12 Suppl 1:S67-70.

PMID:
17935280
20.

Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.

Tse AK, Wan CK, Shen XL, Yang M, Fong WF.

Biochem Pharmacol. 2005 Nov 15;70(10):1443-57. Epub 2005 Sep 21.

PMID:
16181613

Supplemental Content

Support Center